Maternal Weight Intervention in the Perinatal Period Improves Liver Health in the Offspring of Mothers with Obesity
Nutrients · 2023
DOI: 10.3390/nu16010109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Amanda R Purcell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Kolling Institute of Medical Research, St Leonards, NSW 2065, Australia. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Early-life exposure to maternal obesity predisposes offspring to metabolic-associated fatty liver disease (MAFLD). This study aimed to determine if peripartum weight loss, either through dietary intervention or pharmacological intervention, improved adverse liver health outcomes in the offspring of mothers with obesity. C57Bl/6 dams were fed a chow diet or a high-fat diet (HFD) for 8 weeks. HFD-fed mice either continued HFD, transitioned to a chow diet, or were administered liraglutide for 4 weeks. Pregnancy was induced following a one-week washout of liraglutide during which all animals remained on their respective diets. A proportion of HFD-fed mice transitioned to a chow diet during pregnancy. All offspring were weaned to the HFD. Offspring anthropometric, metabolic, and hepatic outcomes were assessed at postnatal week 12. The offspring of mothers with obesity had phenotypic changes consistent with MAFLD. The offspring of mothers that had weight loss with perinatal dietary intervention had reduced insulin resistance (p < 0.001) and hepatic expression of markers of inflammation (p < 0.001), oxidative stress (p < 0.05), and fibrosis (p < 0.05). A similar phenotype was observed in the offspring of mothers with pre-pregnancy weight loss via liraglutide despite ongoing consumption of the HFD during pregnancy. All methods and timing of maternal weight intervention were effective at ameliorating adverse liver effects in the offspring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kolling Institute of Medical Research, St Leonards, NSW 2065, Australia.
- North Precinct, Sydney Medical School, University of Sydney, Sydney, NSW 2065, Australia.
- Department of Diabetes, Endocrinology and Metabolism, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
- Department of Diabetes and Endocrinology, Nepean Hospital, Sydney, NSW 2747, Australia.
- NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
ORCID-Profile: Qinghua Cao, Sarah J Glastras
Zitieren
APA
Purcell, A. R., Rodrigo, N., Cao, Q., Joseph, O., Gill, A. J., Saad, S., Pollock, C. A., & Glastras, S. J. (2023). Maternal Weight Intervention in the Perinatal Period Improves Liver Health in the Offspring of Mothers with Obesity. Nutrients. https://doi.org/10.3390/nu16010109
Vancouver
Purcell AR, Rodrigo N, Cao Q, Joseph O, Gill AJ, Saad S, et al. Maternal Weight Intervention in the Perinatal Period Improves Liver Health in the Offspring of Mothers with Obesity. Nutrients. 2023. doi:10.3390/nu16010109
BibTeX
@article{Purcell2023,
author = {Purcell, Amanda R and Rodrigo, Natassia and Cao, Qinghua and Joseph, Olivia and Gill, Anthony J and Saad, Sonia and Pollock, Carol A and Glastras, Sarah J},
title = {Maternal Weight Intervention in the Perinatal Period Improves Liver Health in the Offspring of Mothers with Obesity},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu16010109}
}
EUVIMED